Link to this page
Medical Subject Headings
Last uploaded:
January 16, 2025
Jump to:
| Id | http://purl.bioontology.org/ontology/MESH/D000068878
http://purl.bioontology.org/ontology/MESH/D000068878
|
|---|---|
| Preferred Name | Trastuzumab |
| Definitions |
A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
|
| Synonyms |
Trazimera
Herceptin
Trastuzumab-qyyp
Trastuzumab beta
beta, Trastuzumab
Trastuzumab qyyp
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed. |
|---|---|
| altLabel |
Trazimera
Herceptin
Trastuzumab-qyyp
Trastuzumab beta
beta, Trastuzumab
Trastuzumab qyyp
See more
See less
|
| prefLabel |
Trastuzumab
|
| TH |
US
UK
CA
NLM (2020)
FDA SRS (2013)
ES
NLM (2021)
USAN (19XX)
INN (19XX)
DE
AU
NLM (1998)
FR
IE
See more
See less
|
| notation |
D000068878
|
| RR |
180288-69-1
|
| DX |
20160101
|
| Machine permutation |
2016; TRASTUZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 1998-2015
|
| MN |
D12.776.124.486.485.114.224.060.875
D12.776.377.715.548.114.224.200.875
D12.776.124.790.651.114.224.060.875
|
| PA |
D000074322
|
| FX |
D018719
|
| MMR |
20200206
|
| Mapped from |
See more
See less
|
| AQL |
AD AE AN BI BL CF CH CL DE EC GE HI IM IP ME PD PH PK PO RE TO TU UL UR
|
| HN |
2016 (1998)
|
| subClassOf | |
| Semantic type UMLS property | |
| Inverse of RB |
P188ANX8CK
0
|
| LT |
TRD
|
| DC |
1
|
| MDA |
20150701
|
| Inverse of RO | |
| type | |
| tui |
T116
T129
T121
|
| cui |
C4764377
C0728747
C0338204
C4764376
|
| isa | |
| Inverse of AQ |
See more
See less
|
| TERMUI |
T321434
T000994285
T000955031
T000877625
T000955030
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |